TrumpRx

Search documents
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
Benzinga· 2025-10-09 19:09
Prescription savings platform GoodRx Holdings Inc. (NASDAQ:GDRX) is reportedly joining the so-called TrumpRx website, signaling an initiative expansion beyond pharmaceutical manufacturers' direct discount programs.The discussions follow Pfizer Inc‘s (NYSE:PFE) agreement with the Trump Administration to ensure U.S. patients pay lower prices for their prescription medicines.The administration is now hyping TrumpRx as a tool to help consumers access medications at lower prices, though, its real-world value rem ...
Record Closes, Resiliency Define First Week of October
Schaeffers Investment Research· 2025-10-03 16:02
Resiliency was the theme on Wall Street to end September and begin the fourth quarter. Despite a U.S. government shutdown, concerning mid-week jobs data, and a brief AI lull, all three major benchmarks bagged record closes and were set for weekly gains. As of this writing on Friday, the Dow Jones Industrial Average (DJI), S&P 500 (SPX), and Nasdaq Composite (IXIC) were all in the midst of six-day win streaks. Analyst Attention Worth MonitoringThe brokerage community was active this week, with analysts turni ...
Pfizer's Art Of The Deal
Forbes· 2025-10-01 20:30
Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday.Getty ImagesPresident Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks like the pharmaceutical giant got the better end of it. Signed at a showy news conference on Tuesday, the agreement gives CEO Albert Bourla and his company a reprieve from threatened tariffs and something of a truce from an Administration that he had been battling. It was a win so clear that the com ...
Pfizer to cut drug prices, announces $70 billion US investment, and discounted sales via TrumpRx
MINT· 2025-09-30 16:52
Pfizer Inc. is set to unveil plans to lower prescription drug prices at an event on Tuesday alongside President Donald Trump, according to multiple White House officials, as per a report. The announcement will include measures aimed at making medicines more affordable for Americans, particularly those enrolled in the Medicaid program, Bloomberg reported.Pfizer is expected to implement broad reductions in US drug prices, with Medicaid patients receiving “most favored nation” pricing on select medicines, the ...